Aceragen (ACGN.US) directors sold 51 common shares worth approximately $26.01
It was reported on August 12 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 11, $Aceragen (ACGN.US) $ director GOWEN MAXINE sold 51 common shares at an average price of 0.51 US dollars per share on August 10, with a value of about 26.01 US dollars. Image source: SEC's official website What is a statement on changes in shareholding? The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding information. When an insider's shareholding changes, depending on the circumstances, it is necessary to file with the SEC within a certain period of time after the transaction ends
Aceragen (ACGN.US) directors sold 3,283 common shares worth approximately $1,750.17
On August 12, it was reported that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 11, $Aceragen (ACGN.US) $ director MILANO VINCENT sold 3,283 common shares at an average price of 0.5331 US dollars per share on August 10, with a value of about 1,750.17 US dollars. Image source: SEC's official website What is a statement on changes in shareholding? The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding information. When an insider's shareholding changes, depending on the circumstances, it is necessary to do so after the transaction is completed
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersVistagen Therapeutics (NASDAQ:VTGN) stock rose 22.5% to $8.62 during Wednesday's after-market session. Trading volume for this security closed at 4.6 million, accounting for 394.0% of its avera
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session.
Why Aceragen (ACGN) Stock Is Down 30% Today
Aceragen, Inc. (NASDAQ:ACGN) shares are trading lower by 30% to $0.53 Monday morning after the company announced it will delist from the Nasdaq. The company says the delisting process will be orderly
12 Health Care Stocks Moving In Friday's After-Market Session
GainersAkso Health Group (NASDAQ:AHG) stock increased by 10.7% to $0.34 during Friday's after-market session. Akso Health Group's trading volume hit 54.8K shares by close, accounting for 167.6% of its
Aceragen, Inc. to Delist From The Nasdaq Stock Market
DURHAM, N.C. and EXTON, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the "Company") (NASDAQ:ACGN), announced today that the Company intends to voluntarily terminate the listing of its common stock on the
U.S. Shares Mixed at Close of Trade; Dow Jones Industrial Average up 0.23%
Stocks That Hit 52-Week Lows On Wednesday
 Wednesday saw 59 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was TC Energy (NYSE:TRP).China SXT Pharmaceuticals
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 56 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Apellis Pharmaceuticals (NASDAQ:APLS)
12 Health Care Stocks Moving In Friday's Intraday Session
GainersQuoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 36.1% to $8.86 during Friday's regular session. As of 13:30 EST, Quoin Pharmaceuticals's stock is trading at a volume of 5.5 million,
XXII, GP and ACGN Among Mid-day Movers
Stocks That Hit 52-Week Lows On Thursday
 During Thursday's session, 40 stocks hit new 52-week lows. 52-Week Low Highlights: The largest company by market cap to set a new 52-week low was Crown Castle (NYSE:CCI).The smallest company by ma
Aceragen (ACGN.US) shareholders increased their common stock holdings by 27,000 shares, worth approximately US$383,000
It was reported on July 20 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on July 19, $Aceragen (ACGN.US) $ shareholder Pillar Invest Corp increased 27,000 common shares at an average price of 1.42 US dollars per share on May 17, with a value of about 38,300 US dollars; on July 12 and 13, it sold 5,818 common shares at an average price of 1.56 US dollars per share, with a value of about 9,103.92 US dollars. This transaction involves another related party: Pillar Partners Found
Aceragen Receives Non-Compliance Notice From Nasdaq
Aceragen (ACGN) said late Tuesday it received a notice from the Nasdaq Stock Market that the company is not in compliance with listing rules as it has not yet filed its quarterly report on Form 10-Q f
Aceragen Receives Non-compliance Notice From Nasdaq
Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the "Company") (Nasdaq: ACGN), announced today that on May 24, 2023, the Company received a notice from The Nasdaq Stock
Insider Sell: Aceragen
Atul Chopra, 10% Owner, on May 12, 2023, sold 81,486 shares in Aceragen (ACGN) for $126,947. Following the Form 4 filing with the SEC, Chopra has control over a total of 1,340,830 shares of the compan
Immuron, ANI Pharmaceuticals Top Healthcare Gainers; Catalent, Aptorum Among Losers
Aceragen On April 28, 2023, The Board Of Directors Of Aceragen, Inc. Approved A Reduction In Workforce Of Approximately 80%, Effective Immediately, As Part Of Previously Disclosed Cost-Cutting Measures.
Aceragen On April 28, 2023, The Board Of Directors Of Aceragen, Inc. Approved A Reduction In Workforce Of Approximately 80%, Effective Immediately, As Part Of Previously Disclosed Cost-Cutting Measure
No Data